Day One Biopharmaceuticals
DAWN
DAWN
66 hedge funds and large institutions have $430M invested in Day One Biopharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 10 closing their positions.
Holders
66
Holders Change
+8
Holders Change %
+13.79%
% of All Funds
1.04%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
18
Increased
21
Reduced
12
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$60.1M |
2 |
![]()
2
Franklin Resources
San Mateo,
California
|
$15.3M |
3 |
3
BlackRock
New York
|
$11.5M |
4 |
4
Millennium Management
New York
|
$1.73M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$3.2M |